Avalo Therapeutics Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $35 Price Target
在奥本海默将股票从表现上调至跑赢大盘并宣布35美元的目标股价之后,Avalo Therapeutics的股价走高
Avalo Therapeutics Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $35 Price Target
在奥本海默将股票从表现上调至跑赢大盘并宣布35美元的目标股价之后,Avalo Therapeutics的股价走高
使用浏览器的分享功能,分享给你的好友吧